Symrise share buyback program to conclude October 30
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
DeFi Development Sets Nov. 12 Date for Q3 2026 Results
The company plans to publish its financial results and business outlook at approximately 8:00 a.m. Eastern Time on its investor relations website.
M impact | EQUITY | Oct 29, 2026, 01:04 PM UTC
Vanda Pharmaceuticals Reports Q3 Revenue Growth and Raises 2026 Guidance
Vanda reported third-quarter 2026 revenue of $69.8 million, up 24% year over year, and a net loss of $22.6 million, or $0.37 per share, unchanged from a year earlier. It now expect
M impact | EQUITY | Oct 29, 2026, 01:04 PM UTC
Eightco Repurchased More Than 55 Million Shares, Sold Part of OpenAI Stake
Eightco said it repurchased more than 55 million shares under its ongoing $125 million capital return program. It sold part of its non-controlling OpenAI investment, realizing an a
M impact | EQUITY | Oct 29, 2026, 01:04 PM UTC
Cogeco Communications Reports Q4 Results, Forecasts Fiscal 2027 Declines
Cogeco reported positive year-over-year revenue and adjusted EBITDA performance in Canada and re-accelerating Canadian Internet subscriber growth. It forecast fiscal 2027 revenue d
M impact | EQUITY | Oct 29, 2026, 01:04 PM UTC
Core Laboratories Reports Q3 2026 Results, Issues Q4 Guidance
Core Laboratories reported Q3 2026 revenue of $132.1 million, GAAP operating income of $12.1 million and GAAP EPS of $0.12. It projected Q4 revenue of $128.5 million to $134.5 mill
M impact | EQUITY | Oct 29, 2026, 01:04 PM UTC
Opentrons Raises $40 Million in Series E Funding
The round was led by healthcare investor Avego, with participation by BroadOak Capital Partn.
L impact | EQUITY | Oct 29, 2026, 01:03 PM UTC